I10 is a valid billable ICD-10 diagnosis code for Essential (primary) hypertension. It is found in the 2020 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2019 - Sep 30, 2020. Essential hypertension is high blood pressure that doesn't have a known secondary cause.
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
The ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) is a system used by physicians and other healthcare providers to classify and code all diagnoses, symptoms and procedures recorded in conjunction with hospital care in the United States.
Search the full ICD-10 catalog by:
The PF family of lung diseases is part of an even larger group of diseases called interstitial lung diseases (also known as ILD), which includes all of the diseases that have inflammation and/or scarring in the lung.
Interstitial lung disease refers to a group of about 100 chronic lung disorders characterized by inflammation and scarring that make it hard for the lungs to get enough oxygen. The scarring is called pulmonary fibrosis. The symptoms and course of these diseases may vary from person to person.
Interstitial lung disease (ILD) is another term for pulmonary fibrosis, which means “scarring” and “inflammation” of the interstitium (the tissue that surrounds the lung's air sacs, blood vessels and airways). This scarring makes the lung tissue stiff, which can make breathing difficult.
Most ILDs are 'restrictive' pulmonary disorders, i.e., the lungs have a reduced ability to expand on inhalation. This is in contrast to 'obstructive' pulmonary disorders such as asthma, COPD and emphysema, in which the airways of the lungs become narrowed or blocked so the patient cannot exhale completely.
Idiopathic pulmonary fibrosis (IPF) is the most common disease of this type. There are also dozens of known causes of ILD, including: Autoimmune diseases (in which the immune system attacks the body) such as lupus, rheumatoid arthritis, sarcoidosis, and scleroderma.
To diagnose an ILD, your doctor will probably order a chest X-ray or CT scan to get a better look at your lungs. A lung function test may be used to measure your total lung capacity, which may have deteriorated due to the ILD.
There are about five broad categories of Interstitial Lung Diseases: Exposure or occupational related (asbestosis, silicosis, hypersensitivity pneumonitis) Treatment related: chemotherapy, radiation therapy, some medications.
Interstitial lung disease can be caused by long-term exposure to hazardous materials, such as asbestos. Some types of autoimmune diseases, such as rheumatoid arthritis, also can cause interstitial lung disease. In some cases, however, the causes remain unknown. Once lung scarring occurs, it's generally irreversible.
Interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), is a fatal disease with a poor prognosis, and the therapeutic options are limited. [1,2,3] The mean survival time of patients with IPF in Japan is 61 months.
Although chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) have distinct clinical features, both diseases may coexist in a patient because they share similar risk factors such as smoking, male sex, and old age.
Changes in the airways or tissues of the lungs make it hard to breathe. Common causes of chronic obstructive pulmonary disease (COPD) are emphysema, chronic bronchitis, or asthma. These conditions can coexist with ILD.
Idiopathic Pulmonary Fibrosis (IPF) is an interstitial lung disease characterized by chronic inflammation, accompanied by an uncontrolled healing response that causes progressive scarring or thickening (fibrosis) of tissues between the lung's alveoli, or air sacs.